Abstract
We describe a 7-day-old infant who presented with extensive cerebral venous sinus thrombosis (CVST) and was found to be homozygous for the prothrombin G20210A gene mutation. No other known risk factors for thrombosis were identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
DeVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. New Engl J Med 2001;345:417–423.
Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children: A multifactorial origin. Circulation 2003;108:1362–1367.
Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase of venous thrombosis. Blood 1996;88:3698–3703.
Young G, Manco-Johnson M, Gill JC, et al. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost 2003;1:958–962.
Reuner KH, Ruf A, Grau A, et al. Prothrombin Gene20210A transition is a risk factor for cerebral venous thrombosis. Stroke 1998;29:1765–1769.
Aronis S, Bouza H, Pergantou H, et al. Prothrombotic factors in neonates with cerebral thrombosis and intraventricular hemorrhage. Acta Pediatr Suppl 2002;438:87–91.
Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives. New Engl J Med 1998;338:1793–1797.
Kosch A, Junker R, Wermes C, et al. Recurrent pulmonary embolism in a 13-year-old male homozygous for the prothrombin G20210A mutation combined with protein S deficiency and increased lipoprotein (a). Thromb Res 2002;105:49–53.
Vaya A, Garcia M, Mira Y, et al. Homozygous 20210G/A prothrombin gene mutation associated with bilateral iliac vein thrombosis: a case report. Thromb Res 2001;104:293–296.
Souto JC, Mateo J, Soria JM, et al. Homozygotes for prothrombin gene 20210A allele in a thrombophilic family without clinical manifestatios of venous thromboembolism. Haematologica 1999;84:627–632.
Girolami A, Scarano L, Tormene D, et al. Homozygous patients with the 20210 G to A prothrombin polymorphism remain often asymptomatic in spite of the presence of associated risk factors. Clin Appl Thromb Hemost 2001;7:122–125.
Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597–600.
De Bruijn SFTM, Stam J . Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484–488.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, L., Bhardwaj, V. & Gebara, B. Cerebral Venous Sinus Thrombosis in a Neonate with Homozygous Prothrombin G20210A Genotype. J Perinatol 24, 797–799 (2004). https://doi.org/10.1038/sj.jp.7211187
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211187